Dr. Ruedi Gygax
Ruedi Gygax, Dr. Phil II, is active in a number of Swiss institutions that foster entrepreneurship and the start-up of young companies. He is an expert at Innosuisse, member of the boards of BioBAC and Swiss Startup Invest and member of the StartAngelsNetwork. He is currently a board member of AVA AG. From 2008 to 2014 he was managing partner of Nextech AG. From 1996 till 2008, he was Managing Director at the Novartis Venture Fund, where he accompanied a large number of young companies through their foundation, through M&A transactions, turn-around situations. etc. He was a Board member of ~10 of such companies, among others Santhera AG (CH), Chemovation Ltd. (UK), BioCure Ltd. (US) and Covagen AG (CH). Before that, he held various positions in the areas of Process Safety (1978 - 1989) and Material Research (1990 - 1996) at Ciba-Geigy AG, a Swiss Chemical and Life Science company. Dr. Gygax earned his Diploma in Chemistry and PhD in Physical Chemistry from the University of Basel, Switzerland. Before his entry into industry, he was a Post-Doctoral student at Stanford University.